Pharmaceutical Technology3h
Abcuro secures $200m as it eyes approval for rare muscle disease drug
The funding will be used to complete the Phase II/III trial of ulviprubart, and to support commercial launch preparation.
clinicaltrialsarena6h
Moleculin Biotech gains approval for enrolment in trial of AML therapy in Ukraine
Moleculin Biotech has received approval in Ukraine to begin enrolment in its trial of annamycin with cytarabine for acute ...
Mining Technology7h
South32’s Worsley Alumina secures federal environmental approval for mine development
South32 has announced that its Worsley Alumina operations have been granted Federal approval for the Worsley Mine Development ...
Pharmaceutical Technology10h
EC grants marketing authorisation to BridgeBio’s ATTR-CM treatment
EC has granted marketing authorisation to BridgeBio Pharma’s acoramidis under the Beyonttra brand name for treating ATTR-CM.